[Long-term management of complex or difficult psychotic states].
Vacheron
M-N
MN
CHSA, Secteur 13. 1, rue Cabanis 75674, Paris Cedex 14, France. mn.vacheron@ch-sainte-anne.fr
D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D002908:Chronic Disease; D003131:Combined Modality Therapy; D003702:Delusions / Q000175:diagnosis / Q000523:psychology / Q000628:therapy; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D004565:Electroconvulsive Therapy; D006212:Hallucinations / Q000175:diagnosis / Q000523:psychology / Q000628:therapy; D006801:Humans; D011613:Psychotherapy; D011618:Psychotic Disorders / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*
D000927:Anticonvulsants; D014150:Antipsychotic Agents